[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer

van Helden EJ,; Elias, Sg; Gerritse, Sl; van Es SC,; Boon, E; Huisman, Mc; van Grieken NCT,; Dekker, H; van Dongen GAMS,; Vugts, Dj; Boellaard, R; van Herpen CML,; de Vries EGE,; Oyen, W; Brouwers, Ah; Verheul, Hmw; Hoekstra, Os; van Oordt CWM,

doi:10.1007/s00259-019-04555-6

[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer / van Helden, Ej; Elias, Sg; Gerritse, Sl; van Es, Sc; Boon, E; Huisman, Mc; van Grieken, Nct; Dekker, H; van Dongen, Gams; Vugts, Dj; Boellaard, R; van Herpen, Cml; de Vries, Ege; Oyen, W; Brouwers, Ah; Verheul, Hmw; Hoekstra, Os; van Oordt, Cwm. - In: EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. - ISSN 1619-7070. - 47:4(2020), pp. 849-859. [10.1007/s00259-019-04555-6]

Titolo:	[Zr-89]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
Autori:	van Helden EJ Elias SG Gerritse SL van Es SC Boon E Huisman MC van Grieken NCT Dekker H van Dongen GAMS Vugts DJ Boellaard R van Herpen CML de Vries EGE OYEN, Willem Jozef Gerard Brouwers AH Verheul HMW Hoekstra OS van Oordt CWM mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2020
Rivista:	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
Handle:	http://hdl.handle.net/11699/3723
Appare nelle tipologie:	1.1 Articolo in rivista

File in questo prodotto:

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11699/3723

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

CINECA IRIS Institutional Research Information System

File in questo prodotto: